Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Caroline Lindemans

Co-PI, Pediatrician
--

I am a pediatric immunologist and a physician scientist in the field of pediatric blood and bone marrow transplantation. We  transplant children with a range of malignant and non-malignant diseases at the pediatric  stem cell transplant ward at the Princes Maxima Center, each disease with their own challenge. Even with these therapies becoming safer over the years, there remains significant room for safer and less toxic transplant: to improve  both effectivity and decrease toxicity of these in essence curative therapies. I am leading the BMT clinical trials within the early clinical trial unit of the Maxima and  together with Stefan Nierkens we are the current  directors of the M4C Transplantation and immunotherapy.  I maintain an extensive HSCT biobank  with the UMCU adult HCT department that  allows for the biomarker and  immune cell recovery studies in  transplant patients, to related these to foavourable outcomes and the occurrence of specific complications.  My experimental GVHD research line in close collaboration with reseachers  at the Regenerative Medicine Center  of the UMC  Utrecht (Coffer&  Ped gastro lab) focuses on tissue damage as a trigger of immune responses using the human 3D intestinal organoid model.

  • Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy

    • apr. 2024
    • Shanice, Beerepoot, et al
    • Journal of Neurology
  • High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant

    • jan. 2024
    • Rick, Admiraal, et al
    • Cytotherapy
  • Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis

    • sep. 2023
    • Alexandre G, Troullioud Lucas, et al
    • Cytotherapy
  • Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation

    • jul. 2023
    • Konradin F, Müskens, et al
    • Blood Reviews
  • Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients

    • apr. 2023
    • K L Juliëtte, Schmidt, et al
    • Cancers
View all publications